These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38700393)

  • 1. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic.
    Bleyer A; Barnes B; Finn K
    J Opioid Manag; 2024; 20(2):119-132. PubMed ID: 38700393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. United States marijuana legalization and opioid mortality epidemic during 2010-2020 and pandemic implications.
    Bleyer A; Barnes B; Finn K
    J Natl Med Assoc; 2022 Aug; 114(4):412-425. PubMed ID: 35469600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.
    Shi Y; Liang D; Bao Y; An R; Wallace MS; Grant I
    Drug Alcohol Depend; 2019 Jan; 194():13-19. PubMed ID: 30390550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality.
    Nguyen HV; McGinty EE; Mital S; Alexander GC
    JAMA Health Forum; 2024 Jan; 5(1):e234897. PubMed ID: 38241056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marijuana legalization and opioid deaths.
    Mathur NK; Ruhm CJ
    J Health Econ; 2023 Mar; 88():102728. PubMed ID: 36808015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality.
    Laing R; Donnelly CA
    PLoS One; 2024; 19(7):e0306395. PubMed ID: 38980856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the effect of Colorado's recreational marijuana policy on opioid overdose rates.
    Alcocer JJ
    Public Health; 2020 Aug; 185():8-14. PubMed ID: 32505041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid overdose decedent characteristics during COVID-19.
    Garcia GP; Stringfellow EJ; DiGennaro C; Poellinger N; Wood J; Wakeman S; Jalali MS
    Ann Med; 2022 Dec; 54(1):1081-1088. PubMed ID: 35467475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use.
    Shah A; Hayes CJ; Lakkad M; Martin BC
    J Gen Intern Med; 2019 Aug; 34(8):1419-1426. PubMed ID: 30684198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dynamic Model of Opioid Overdose Deaths in Canada during the Co-Occurring Opioid Overdose Crisis and COVID-19 Pandemic.
    Zahan R; Osgood ND; Plouffe R; Orpana H
    Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-related overdose mortality in the era of fentanyl: Monitoring a shifting epidemic by person, place, and time.
    Althoff KN; Leifheit KM; Park JN; Chandran A; Sherman SG
    Drug Alcohol Depend; 2020 Nov; 216():108321. PubMed ID: 33007700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado.
    Kropp Lopez AK; Nichols SD; Chung DY; Kaufman DE; McCall KL; Piper BJ
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32392702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
    DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
    Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study.
    Hsu G; Kovács B
    BMJ; 2021 Jan; 372():m4957. PubMed ID: 33504472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata.
    Ali MM; McClellan C; Mutter R; Rees DI
    Health Econ; 2023 Feb; 32(2):277-301. PubMed ID: 36335085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.
    Bao Y; Zhang H; Bruera E; Portenoy R; Rosa WE; Reid MC; Wen H
    JAMA Oncol; 2023 Feb; 9(2):206-214. PubMed ID: 36454553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing Individuals.
    Hammond AS; Dunn KE; Strain EC
    J Addict Med; 2020; 14(1):56-62. PubMed ID: 31385846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
    Phillips E; Gazmararian J
    J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic.
    Akbar S; Iacono A; Yang J; Antoniou T; Juurlink D; Sheikh H; Kurdyak P; Wu F; Cheng C; Leece P; Kolla G; Emblem J; Shearer D; Gomes T
    J Adolesc Health; 2024 Jul; 75(1):35-42. PubMed ID: 38597841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Opioid Epidemic: a Crisis Disproportionately Impacting Black Americans and Urban Communities.
    Gondré-Lewis MC; Abijo T; Gondré-Lewis TA
    J Racial Ethn Health Disparities; 2023 Aug; 10(4):2039-2053. PubMed ID: 36068482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.